The Latest Research
on Red Light Therapy

PBMT alone was the strongest recovery option with better muscle force, lower soreness, and lower creatine kinase from 24 to 96 hours compared with cryotherapy, combined treatment, and placebo.

Photomodulation therapy showed moderate to large effects for reducing soreness and restoring strength with consistent benefit over placebo across all 14 included studies.

PBMT ranked first among 9 physical therapy modalities for 24 hour pain reduction with stronger results than cryotherapy, electrical stimulation, sauna, and ultrasound therapy.

Photobiomodulation shows anti inflammatory effects through 5 identified cellular mechanisms with supporting evidence from animal models and human clinical trials for pain and mobility support.

Photobiomodulation consistently reduced pain scores and inflammatory markers across 11 RCTs covering tendinopathy, joint pain, and myofascial pain conditions.

Across more than 9,000 patients and 15 meta analyses, photobiomodulation showed positive outcomes across common joint conditions from knee osteoarthritis to Achilles tendinopathy.

Red light treatment significantly improved sleep quality, increased serum melatonin, and reduced sleep latency with melatonin gains directly linked to better sleep scores.

Prefrontal cortex photobiomodulation improved objective sleep efficiency and working memory with measurable improvement within 5 consecutive sessions.

Transcranial photobiomodulation may increase melatonin, reduce neuroinflammation, and improve sleep quality with positive results reported across healthy and clinical sleep populations.

Transcranial photobiomodulation significantly improved cognitive function and increased BDNF which is a key marker of neuroplasticity in adults with mild cognitive impairment. Effects were sustained at the 150 day follow up.

82.9% of human transcranial photobiomodulation studies reported positive cognitive outcomes with every mild cognitive impairment and dementia study in the review showing benefit across memory, learning, and attention.

Transcranial photobiomodulation produced measurable working memory improvement within 5 treatment sessions which is strong randomized evidence for a rapid cognitive effect from targeted near infrared light therapy.

Low level light therapy may release nitric oxide from cytochrome c oxidase and haemoglobin stores which may increase local blood flow and oxygen delivery through vasodilation.

Near infrared photobiomodulation at 808nm was linked to cerebral blood flow increases of up to 30% with vascular effects reported in human clinical investigations.

LED and near infrared light may support tissue oxygenation and local circulation while also helping reduce oxidative stress in vessel walls.

Photobiomodulation showed anti inflammatory outcomes across all 5 inflammation driven conditions reviewed with evidence drawn from more than 9,000 patients in 15 separate meta analyses.

Photobiomodulation reduced both pain scores and objective inflammatory markers across most of the included trials which supports both analgesic and anti inflammatory effects in chronic musculoskeletal conditions.

Red and near infrared LED may reduce MMP expression, lower pro inflammatory interleukin activity, and modulate reactive oxygen species which together supports a clear molecular basis for anti inflammatory action.

The light therapy helmet was significantly better than sham for hair density and hair diameter at 24 weeks in both male and female patients with minimal adverse effects.

Light therapy at 655nm significantly improved hair counts compared with placebo and helped establish the evidence base for FDA cleared devices in androgenetic alopecia.

Light therapy significantly increased hair density versus sham in both sexes with effectiveness confirmed across device types, treatment durations, and wavelengths from 630 to 808nm.